Cargando…

Spatiotemporal Characterization of mTOR Kinase Activity Following Kainic Acid Induced Status Epilepticus and Analysis of Rat Brain Response to Chronic Rapamycin Treatment

Mammalian target of rapamycin (mTOR) is a protein kinase that senses nutrient availability, trophic factors support, cellular energy level, cellular stress, and neurotransmitters and adjusts cellular metabolism accordingly. Adequate mTOR activity is needed for development as well as proper physiolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macias, Matylda, Blazejczyk, Magdalena, Kazmierska, Paulina, Caban, Bartosz, Skalecka, Agnieszka, Tarkowski, Bartosz, Rodo, Anna, Konopacki, Jan, Jaworski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665782/ https://www.ncbi.nlm.nih.gov/pubmed/23724051 http://dx.doi.org/10.1371/journal.pone.0064455

Ejemplares similares

Kainic Acid Induces mTORC1-Dependent Expression of Elmo1 in Hippocampal Neurons
por: Blazejczyk, Magdalena, et al.
Publicado: (2016)

Adaptor Complex 2 Controls Dendrite Morphology via mTOR-Dependent Expression of GluA2
por: Koscielny, Alicja, et al.
Publicado: (2017)

GSK3β Controls mTOR and Prosurvival Signaling in Neurons
por: Urbanska, Malgorzata, et al.
Publicado: (2017)

mTOR kinase is needed for the development and stabilization of dendritic arbors in newly born olfactory bulb neurons
por: Skalecka, Agnieszka, et al.
Publicado: (2016)

Perspective on mTOR-dependent Protection in Status Epilepticus
por: Biagioni, Francesca, et al.
Publicado: (2022)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018)

Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor
por: Artoni, Filippo, et al.
Publicado: (2023)

Neuroprotective Effects of Exogenous Irisin in Kainic Acid-Induced Status Epilepticus
por: Cheng, Yao, et al.
Publicado: (2021)

Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
por: Lin, Hugo You-Hsien, et al.
Publicado: (2014)

The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
por: Yoon, Mee-Sup
Publicado: (2017)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation
por: Urbanska, Malgorzata, et al.
Publicado: (2018)

Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
por: Yang, Ming-Tao, et al.
Publicado: (2017)

GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer
por: Scott, Kenneth L., et al.
Publicado: (2009)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
por: Seto, Belinda
Publicado: (2012)

mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain
por: Yang, Haijuan, et al.
Publicado: (2013)

Brain size is controlled by the mammalian target of rapamycin (mTOR) in mice
por: Kim, Woo-Yang
Publicado: (2015)

The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
por: Maiese, Kenneth
Publicado: (2020)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
por: Zhao, Wei, et al.
Publicado: (2023)

Myoinositol Attenuates the Cell Loss and Biochemical Changes Induced by Kainic Acid Status Epilepticus
por: Tsverava, Lia, et al.
Publicado: (2016)

Mode-Dependent Effect of Xenon Inhalation on Kainic Acid-Induced Status Epilepticus in Rats
por: Zhang, Yurong, et al.
Publicado: (2019)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
por: Spormann, Luise, et al.
Publicado: (2020)

ESCRT Proteins Control the Dendritic Morphology of Developing and Mature Hippocampal Neurons
por: Firkowska, Marcelina, et al.
Publicado: (2018)

Regulation of Gene Expression in Hepatic Cells by the Mammalian Target of Rapamycin (mTOR)
por: Jimenez, Rosa H., et al.
Publicado: (2010)

Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
por: García-Martínez, Juan M., et al.
Publicado: (2009)

The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice
por: Hartman, Adam L., et al.
Publicado: (2012)

The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
por: Soliman, Ghada A.
Publicado: (2013)

Rapamycin directly activates lysosomal mucolipin TRP channels independent of mTOR
por: Zhang, Xiaoli, et al.
Publicado: (2019)

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in Neurodegeneration
por: Norwitz, Nicholas G., et al.
Publicado: (2020)

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
por: Wu, Minmin, et al.
Publicado: (2020)

Pu-Erh tea and GABA attenuates oxidative stress in kainic acid-induced status epilepticus
por: Hou, Chien-Wei
Publicado: (2011)

Evidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in Mice
por: Sabilallah, Mounira, et al.
Publicado: (2016)

Multi-omics profile of the mouse dentate gyrus after kainic acid-induced status epilepticus
por: Schouten, Marijn, et al.
Publicado: (2016)

Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia
por: Park, Jin-A, et al.
Publicado: (2017)

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer
por: Chan, S
Publicado: (2004)

New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
por: Carraway, Hetty, et al.
Publicado: (2004)

Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin
por: Saito, Keita, et al.
Publicado: (2012)

Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u0p6uo9h3shi44lro74m3fto0m